The decision is a successful outcome for the Heerlen-based company, which in September last year applied for the use of the novel food Schizochytrium sp. Oil for fruit and vegetable purees.
However, the existing conditions of use of the oil remained unchanged as the EC did not ask the European Food Safety Authority (EFSA) for an opinion on the approval of the extension that maintained the Union’s later update and did not raise any safety concerns.
Directive 2002/46 / EC.
The entryFor ‘Schizochytrium sp. Oil ‘now includes conditions under which the novel food can be used. This includes certain food categories such as food supplements within the meaning of Directive 2002/46 / EC.
The maximum allowable DHA level is 250 milligrams (mg) of the omega-3 fatty acid, docosahexaenoic acid (DHA) / day for the general population and 450 mg DHA / day for pregnant and breastfeeding women.
Meanwhile, a limit of 200 mg / 100 g DHA is safe for use in products such as foods that are designed to cover the expense of intense muscle exertion, especially for athletes.
The limit also applies to milk-based drinks and similar products for toddlers, as well as to processed grain-based foods and baby food for infants and toddlers within the meaning of Regulation (EU) No. 609/2013.
Dairy products (excluding milk-based drinks) are another food category where the maximum DHA content is 200 milligrams (mg) / 100 grams (g) or, for cheese products, 600 mg / 100 g.
Milk analogs, with the exception of beverages, are allowed with a maximum DHA content of 200 mg / 100 g, or for analogues of cheese products with 600 mg / 100 g.
Additional specific labeling requirements have also been outlined, with the novel food being labeled as “oil from the microalgae Schizochytrium sp.” On the label of the food containing the oil.
Life’s DHA from DSM.
DSM’s commitment to algae omega-3 oils dates back to 2013, when the company’s own DHA line of Life’sDHA made from algae was launched.
The oil comes from microalgae grown in fermenters with a size of 80,000 to 260,000 liters.
Once grown, the microalgae are harvested and processed to extract a clear, amber-colored oil that is rich in DHA.
In January 2018, DSM and Evonik founded Veramaris, a new company that produces omega-3 fatty acids from natural seaweed for animal nutrition.
The joint venture, headquartered on the DSM Biotech Campus in Delft, Netherlands, enables the production of omega-3 fatty acids without the use of fish oil from wild-caught fish, a finite resource.